Although accumulating evidence confirmed the participating of KPNA2 in the progression of tumour, little is known about the oncogene effects of KPNA2 in ccRCC, as well as its potential effective function for suppression of ccRCC development. The gene discussed is KPNA2; the disease is nonpapillary renal cell carcinoma.